Logo image of ICAD.PA

ICADE (ICAD.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ICAD - FR0000035081 - REIT

21.1 EUR
-0.28 (-1.31%)
Last: 1/12/2026, 4:40:03 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ICAD. ICAD was compared to 42 industry peers in the Diversified REITs industry. ICAD may be in some trouble as it scores bad on both profitability and health. ICAD has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ICAD was profitable.
In the past year ICAD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ICAD reported negative net income in multiple years.
In the past 5 years ICAD always reported a positive cash flow from operatings.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

With a Return On Assets value of -1.84%, ICAD is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
ICAD has a Return On Equity of -4.78%. This is amonst the worse of the industry: ICAD underperforms 83.33% of its industry peers.
ICAD's Return On Invested Capital of 2.76% is on the low side compared to the rest of the industry. ICAD is outperformed by 73.81% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ICAD is in line with the industry average of 3.45%.
The last Return On Invested Capital (2.76%) for ICAD is above the 3 year average (2.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.84%
ROE -4.78%
ROIC 2.76%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

The Operating Margin of ICAD (19.60%) is worse than 80.95% of its industry peers.
ICAD's Operating Margin has declined in the last couple of years.
ICAD does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 19.6%
PM (TTM) N/A
GM N/A
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

ICAD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ICAD remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ICAD has more shares outstanding
The debt/assets ratio for ICAD is higher compared to a year ago.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

ICAD has an Altman-Z score of 0.64. This is a bad value and indicates that ICAD is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ICAD (0.64) is worse than 64.29% of its industry peers.
The Debt to FCF ratio of ICAD is 45.31, which is on the high side as it means it would take ICAD, 45.31 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ICAD (45.31) is worse than 78.57% of its industry peers.
ICAD has a Debt/Equity ratio of 0.97. This is a neutral value indicating ICAD is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.97, ICAD is not doing good in the industry: 73.81% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.31
Altman-Z 0.64
ROIC/WACC0.96
WACC2.88%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

ICAD has a Current Ratio of 1.06. This is a normal value and indicates that ICAD is financially healthy and should not expect problems in meeting its short term obligations.
ICAD's Current ratio of 1.06 is amongst the best of the industry. ICAD outperforms 80.95% of its industry peers.
ICAD has a Quick Ratio of 1.06. This is a bad value and indicates that ICAD is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.81, ICAD is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.81
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1

3. Growth

3.1 Past

ICAD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.25%.
Measured over the past years, ICAD shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.69% on average per year.
The Revenue for ICAD has decreased by -13.82% in the past year. This is quite bad
ICAD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.64% yearly.
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%

3.2 Future

The Earnings Per Share is expected to decrease by -3.40% on average over the next years.
ICAD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.44% yearly.
EPS Next Y8.78%
EPS Next 2Y0.24%
EPS Next 3Y-3.4%
EPS Next 5YN/A
Revenue Next Year-6.32%
Revenue Next 2Y-3.05%
Revenue Next 3Y-2.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

ICAD is valuated cheaply with a Price/Earnings ratio of 7.08.
ICAD's Price/Earnings ratio is rather cheap when compared to the industry. ICAD is cheaper than 90.48% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.19, ICAD is valued rather cheaply.
With a Price/Forward Earnings ratio of 6.65, the valuation of ICAD can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICAD indicates a rather cheap valuation: ICAD is cheaper than 97.62% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ICAD to the average of the S&P500 Index (23.92), we can say ICAD is valued rather cheaply.
Industry RankSector Rank
PE 7.08
Fwd PE 6.65
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ICAD is valued cheaper than 95.24% of the companies in the same industry.
ICAD's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. ICAD is more expensive than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.59
EV/EBITDA 10.56
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ICAD's earnings are expected to decrease with -3.40% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y0.24%
EPS Next 3Y-3.4%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.40%, ICAD is a good candidate for dividend investing.
ICAD's Dividend Yield is comparable with the industry average which is at 4.99.
Compared to an average S&P500 Dividend Yield of 1.92, ICAD pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.4%

5.2 History

The dividend of ICAD has a limited annual growth rate of 1.04%.
Dividend Growth(5Y)1.04%
Div Incr Years1
Div Non Decr Years1
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

ICAD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-186.23%
EPS Next 2Y0.24%
EPS Next 3Y-3.4%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

ICADE

EPA:ICAD (1/12/2026, 4:40:03 PM)

21.1

-0.28 (-1.31%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-22 2025-10-22
Earnings (Next)02-16 2026-02-16/amc
Inst Owners73.16%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.61B
Revenue(TTM)1.50B
Net Income(TTM)-186.70M
Analysts51.82
Price Target23.8 (12.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.4%
Yearly Dividend4.84
Dividend Growth(5Y)1.04%
DP-186.23%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.57%
PT rev (3m)-4.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.8%
EPS NY rev (3m)-1.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE 7.08
Fwd PE 6.65
P/S 1.07
P/FCF 15.59
P/OCF 4.9
P/B 0.41
P/tB 0.42
EV/EBITDA 10.56
EPS(TTM)2.98
EY14.12%
EPS(NY)3.18
Fwd EY15.05%
FCF(TTM)1.35
FCFY6.42%
OCF(TTM)4.3
OCFY20.4%
SpS19.67
BVpS51.19
TBVpS50.76
PEG (NY)0.81
PEG (5Y)N/A
Graham Number58.58
Profitability
Industry RankSector Rank
ROA -1.84%
ROE -4.78%
ROCE 3.87%
ROIC 2.76%
ROICexc 3.38%
ROICexgc 3.4%
OM 19.6%
PM (TTM) N/A
GM N/A
FCFM 6.88%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ROICexc(3y)2.49%
ROICexc(5y)2.67%
ROICexgc(3y)2.5%
ROICexgc(5y)2.68%
ROCE(3y)3.06%
ROCE(5y)3.38%
ROICexgc growth 3Y-8.78%
ROICexgc growth 5Y2.92%
ROICexc growth 3Y-8.79%
ROICexc growth 5Y2.96%
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.31
Debt/EBITDA 9.41
Cap/Depr 210.38%
Cap/Sales 15%
Interest Coverage 4.11
Cash Conversion 81.88%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.81
Altman-Z 0.64
F-Score5
WACC2.88%
ROIC/WACC0.96
Cap/Depr(3y)678.24%
Cap/Depr(5y)1255.8%
Cap/Sales(3y)20.42%
Cap/Sales(5y)31.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
EPS Next Y8.78%
EPS Next 2Y0.24%
EPS Next 3Y-3.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%
Revenue Next Year-6.32%
Revenue Next 2Y-3.05%
Revenue Next 3Y-2.44%
Revenue Next 5YN/A
EBIT growth 1Y74.88%
EBIT growth 3Y-29.53%
EBIT growth 5Y-3.23%
EBIT Next Year51.05%
EBIT Next 3Y13.12%
EBIT Next 5Y8.67%
FCF growth 1Y240.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.65%
OCF growth 3Y-11.53%
OCF growth 5Y-0.14%

ICADE / ICAD.PA FAQ

What is the ChartMill fundamental rating of ICADE (ICAD.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICAD.PA.


What is the valuation status of ICADE (ICAD.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to ICADE (ICAD.PA). This can be considered as Fairly Valued.


How profitable is ICADE (ICAD.PA) stock?

ICADE (ICAD.PA) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for ICAD stock?

The Price/Earnings (PE) ratio for ICADE (ICAD.PA) is 7.08 and the Price/Book (PB) ratio is 0.41.


What is the earnings growth outlook for ICADE?

The Earnings per Share (EPS) of ICADE (ICAD.PA) is expected to grow by 8.78% in the next year.